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Each stage of cell culture process development requires fit for purpose tools. The selection of a fed-batch
cultivation system is often based on throughput and cost. However, the process knowledge derived from
different systems and scales is not necessarily identical. Hence, a careful evaluation of systems which are
already established or newly implemented is essential. We recently introduced a novel high throughput fedbatch screening system (1) and the objective of this study was to provide data on how it compares with other
systems used in early and late stage cell culture process development. We describe the performance of 12
different recombinant CHO cell lines expressing the same antibody in fed-batch culture systems ranging from a
few hundred microliters to lab scale. The 12 cell lines were selected based on distinct phenotypes covering a
range which can be expected in typical industrial process development projects. The cell lines were cultivated
using the same expansion and fed-batch protocol (proprietary fed-batch system). The following cultivation
systems were evaluated: shaking 96-deepwell plates, 50 mL vented shake tubes, micro-scale bioreactors
(ambr15TM system) and lab-scale bioreactors (3L). The results of this study show both the limitations and the
potential of each cultivation system and their suitability for process development, process characterization and
scale-up. The shaking systems offer unprecedented parallel throughput but are limited with respect to culture
control (e. g. lack of pH and pO2 control). Despite their limitations, they are expected to be used in the future as
important tools for early process development and for the improvement of fed-batch platform processes. On the
other hand, the data obtained from this study show that micro- and lab-scale bioreactors represent ideal tools for
the confirmation of process consistency. Both micro- and lab-scale systems will be extensively used in the future
to support tech transfers and perform process characterization studies.
(1) Rouiller Y. et al. Modulation of mAb quality attributes using microliter scale fed-batch cultures. Biotechol Prog
2014, 30(3):571-83.

